Cordis Launches Saber PTA Dilatation Balloon for Peripheral Arterial Disease

 

July 11, 2014

Cordis Corp.'s Saber PTA (percutaneous transluminal angioplasty) dilatation catheter is for the treatment of patients with peripheral arterial disease (PAD). The Saber catheter is cleared for use and available in Europe, the United States and Japan. This product offers crossability and a comprehensive offering of balloon sizes on the widely used 0.018-inch over-the-wire (OTW) platform.

Developed to complement the Cordis PTA portfolio as a next-generation, high-performance workhorse 0.018-inch PTA balloon catheter, Saber is intended to dilate stenoses in iliac, femoral, ilio-femoral, popliteal, infrapopliteal and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The device is also indicated for post-dilation of balloon-expandable and self-expanding stents in the peripheral vasculature.

Saber is available in balloon diameters of 2-10 mm and lengths of 20-300 mm. It combines a durable dual layer hydrophilic coating with a low-profile body and new molded tip design to enhance crossability. The catheter has exceptional rated burst pressures of up to 18 atm due to its construction with Duralyn material

For more information: www.cordis.com